Biomodex Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 14

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $217K

Biomodex General Information

Description

Developer of a 3D-printing technology designed for patient-specific rehearsal and physicians' advanced training. The company's technology combines biomechanical and imaging properties and fluid dynamics and is fully integrated into both the imaging and procedural workflow, enabling treating physicians to increase their preparedness and confidence and ultimately reducing surgical medical errors and medical costs.

Contact Information

Website
www.biomodex.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 2 rue de la Roquette
  • 75011 Paris
  • France
Primary Industry
Other Devices and Supplies
Other Industries
Other Healthcare Technology Systems
Acquirer
Mentice
Vertical(s)
3D Printing, Manufacturing, Artificial Intelligence & Machine Learning, Life Sciences
Corporate Office
  • 2 rue de la Roquette
  • 75011 Paris
  • France

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Biomodex Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Merger/Acquisition 11-Dec-2023 $217K Completed Generating Revenue
7. Secondary Transaction - Private Completed Generating Revenue
6. Later Stage VC 29-May-2020 Completed Generating Revenue
5. Early Stage VC 04-Oct-2019 Completed Generating Revenue
4. Early Stage VC (Series A) 30-May-2018 Completed Generating Revenue
3. Early Stage VC (Series A) 11-Apr-2016 Completed Generating Revenue
2. Accelerator/Incubator 02-Oct-2015 $901K $901K Completed Generating Revenue
1. Accelerator/Incubator 05-May-2015 Completed Generating Revenue
To view Biomodex’s complete valuation and funding history, request access »

Biomodex Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
OCABSA
B Shares
ABSA-B2018 33,105 $0.109088 $60.41 $60.41 $60.41 7.68%
A Shares 133,200 $0.109088 $22.11 $22.11 $22.11 30.92%
To view Biomodex’s complete cap table history, request access »

Biomodex Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a 3D-printing technology designed for patient-specific rehearsal and physicians' advanced training. The com
Other Devices and Supplies
Paris, France
14 As of 2023

Miami, FL
 

Los Angeles, CA
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Biomodex Competitors (11)

One of Biomodex’s 11 competitors is Gaumard, a Corporation company based in Miami, FL.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Gaumard Corporation Miami, FL
SprintRay Venture Capital-Backed Los Angeles, CA
Mentice Formerly VC-backed Gothenburg, Sweden
Siemens Healthineers Corporation Forchheim, Germany
Limbs & Things Corporation Bristol, United Kingdom
You’re viewing 5 of 11 competitors. Get the full list »

Biomodex Patents

  • 25

    Total Documents Applications and Grants

  • Total Patents Families

  • 6

    Granted

  • 11

    Pending

  • Expiring in next 12 mo

Biomodex Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240336012-A1 Devices, systems, and methods for 3d printing of vasculature Pending 02-Aug-2021
US-20240355228-A1 System for advanced physician training and patient specific rehearsals Pending 25-Jul-2021
EP-4272201-A1 System for advanced physician training and patient specific rehearsals Pending 30-Dec-2020
US-20240071253-A1 System for advanced physician training and patient specific rehearsals Pending 30-Dec-2020
EP-4085447-A1 Multi-material three-dimensional printed portion of a heart Pending 30-Dec-2019 G09B23/30
To view Biomodex’s complete patent history, request access »

Biomodex Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biomodex Former Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Agoranov Accelerator/Incubator Minority
Idinvest Partners PE/Buyout Minority
InnovAllianz Corporate Venture Capital Minority
Innovation Capital (Paris) Venture Capital Minority
Inserm Transfert VC-Backed Company Minority
You’re viewing 5 of 9 investors. Get the full list »

Ready to get started?

Request a free trial

Biomodex FAQs

  • When was Biomodex founded?

    Biomodex was founded in 2015.

  • Where is Biomodex headquartered?

    Biomodex is headquartered in Paris, France.

  • What is the size of Biomodex?

    Biomodex has 14 total employees.

  • What industry is Biomodex in?

    Biomodex’s primary industry is Other Devices and Supplies.

  • Is Biomodex a private or public company?

    Biomodex is a Private company.

  • What is the current valuation of Biomodex?

    The current valuation of Biomodex is .

  • What is Biomodex’s current revenue?

    The current revenue for Biomodex is .

  • How much funding has Biomodex raised over time?

    Biomodex has raised $26.7M.

  • Who are Biomodex’s investors?

    Agoranov, Idinvest Partners, InnovAllianz, Innovation Capital (Paris), and Inserm Transfert are 5 of 9 investors who have invested in Biomodex.

  • Who are Biomodex’s competitors?

    Gaumard, SprintRay, Mentice, Siemens Healthineers, and Limbs & Things are some of the 11 competitors of Biomodex.

  • When was Biomodex acquired?

    Biomodex was acquired on 11-Dec-2023.

  • Who acquired Biomodex?

    Biomodex was acquired by Mentice.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »